Synairgen Historical Income Statement

Stocks . UK . 
Stock . Synairgen plc
SNG Stock   1.00  0.05  4.76%   
Historical analysis of Synairgen Plc income statement accounts such as Research Development of 6.1 M, Cost Of Revenue of 76.1 K, Total Operating Expenses of 7.5 M or Total Other Income Expense Net of 600.1 K can show how well Synairgen plc performed in making a profits. Evaluating Synairgen Plc income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Synairgen Plc's future profits or losses.
Cash Flow   Balance Sheet     Income Statement
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Synairgen plc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Synairgen plc is a good buy for the upcoming year.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Synairgen plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About Synairgen Income Statement Analysis

Synairgen plc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Synairgen Plc shareholders. The income statement also shows Synairgen investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Balance Sheet
Statement
Details
Cash Flow
Statement
Details

Synairgen Plc Income Statement Chart

At present, Synairgen Plc's Total Other Income Expense Net is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 4.5 M, whereas Gross Profit is projected to grow to (71.8 K).
Other Operating Expenses  Research Development  Total Operating Expenses  Total Other Income Expense Net  
Add Fundamental

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Synairgen plc. It is also known as Synairgen Plc overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most accounts from Synairgen Plc's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Synairgen plc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Synairgen plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
At present, Synairgen Plc's Total Other Income Expense Net is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 4.5 M, whereas Gross Profit is projected to grow to (71.8 K).
 2022 2023 2024 2025 (projected)
Interest Income207K635K730.3K766.8K
Net Interest Income207K635K730.3K766.8K

Synairgen Plc income statement Correlations

Depreciation And Amortization
Interest Expense
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Research Development
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Net Income
Income Tax Expense
Selling General Administrative
Net Income From Continuing Ops
Tax Provision
Net Interest Income
Interest Income
Selling And Marketing Expenses
Reconciled Depreciation
Depreciation And Amortization
0.09-0.930.66-0.66-0.650.65-0.650.920.66-0.660.04-0.65-0.72-0.01-0.64-0.680.030.040.540.93
Interest Expense
0.09-0.140.12-0.12-0.10.05-0.10.140.13-0.110.91-0.13-0.020.75-0.120.040.880.880.130.18
Gross Profit
-0.93-0.14-0.680.680.68-0.670.68-0.97-0.680.68-0.120.670.740.010.660.69-0.1-0.11-0.58-0.96
Other Operating Expenses
0.660.12-0.68-1.0-0.991.0-0.990.691.0-1.00.05-1.0-0.99-0.04-0.99-0.980.040.050.780.67
Operating Income
-0.66-0.120.68-1.01.0-1.01.0-0.69-1.01.0-0.051.00.990.040.990.98-0.04-0.04-0.78-0.67
Ebit
-0.65-0.10.68-0.991.0-0.991.0-0.68-0.991.0-0.031.00.990.071.00.98-0.02-0.02-0.78-0.67
Research Development
0.650.05-0.671.0-1.0-0.99-0.990.671.0-1.0-0.01-1.0-0.99-0.09-0.99-0.99-0.01-0.010.760.66
Ebitda
-0.65-0.10.68-0.991.01.0-0.99-0.68-0.991.0-0.031.00.980.071.00.98-0.02-0.02-0.78-0.66
Cost Of Revenue
0.920.14-0.970.69-0.69-0.680.67-0.680.69-0.680.12-0.67-0.740.0-0.67-0.70.110.120.560.97
Total Operating Expenses
0.660.13-0.681.0-1.0-0.991.0-0.990.69-1.00.06-1.0-0.99-0.04-0.99-0.980.040.050.780.66
Income Before Tax
-0.66-0.110.68-1.01.01.0-1.01.0-0.68-1.0-0.041.00.990.060.990.98-0.02-0.03-0.78-0.67
Total Other Income Expense Net
0.040.91-0.120.05-0.05-0.03-0.01-0.030.120.06-0.04-0.050.030.93-0.040.080.990.99-0.150.17
Net Income
-0.65-0.130.67-1.01.01.0-1.01.0-0.67-1.01.0-0.050.980.050.990.98-0.04-0.04-0.78-0.66
Income Tax Expense
-0.72-0.020.74-0.990.990.99-0.990.98-0.74-0.990.990.030.980.110.980.990.040.03-0.75-0.73
Selling General Administrative
-0.010.750.01-0.040.040.07-0.090.070.0-0.040.060.930.050.110.060.170.950.95-0.390.06
Net Income From Continuing Ops
-0.64-0.120.66-0.990.991.0-0.991.0-0.67-0.990.99-0.040.990.980.060.98-0.03-0.03-0.78-0.65
Tax Provision
-0.680.040.69-0.980.980.98-0.990.98-0.7-0.980.980.080.980.990.170.980.090.09-0.75-0.69
Net Interest Income
0.030.88-0.10.04-0.04-0.02-0.01-0.020.110.04-0.020.99-0.040.040.95-0.030.091.0-0.180.17
Interest Income
0.040.88-0.110.05-0.04-0.02-0.01-0.020.120.05-0.030.99-0.040.030.95-0.030.091.0-0.180.18
Selling And Marketing Expenses
0.540.13-0.580.78-0.78-0.780.76-0.780.560.78-0.78-0.15-0.78-0.75-0.39-0.78-0.75-0.18-0.180.54
Reconciled Depreciation
0.930.18-0.960.67-0.67-0.670.66-0.660.970.66-0.670.17-0.66-0.730.06-0.65-0.690.170.180.54
Click cells to compare fundamentals

Synairgen Plc Account Relationship Matchups

High Positive Relationship

Research Development
+ 1.0
Other Operating Expenses
Total Operating Expenses
+ 1.0
Other Operating Expenses
Ebit
+ 1.0
Operating Income
Ebitda
+ 1.0
Operating Income
Income Before Tax
+ 1.0
Operating Income
Net Income
+ 1.0
Operating Income

High Negative Relationship

Net Income
- 1.0
Total Operating Expenses
Income Before Tax
- 1.0
Total Operating Expenses
Net Income
- 1.0
Research Development
Income Before Tax
- 1.0
Research Development
Total Operating Expenses
- 1.0
Operating Income
Research Development
- 1.0
Operating Income

Synairgen Plc income statement Accounts

202020212022202320242025 (projected)
Depreciation And Amortization260K195K102K84K96.6K82.7K
Interest Expense6K10K2K207K186.3K195.6K
Gross Profit(260K)(195K)(102K)(84K)(75.6K)(71.8K)
Other Operating Expenses17.7M57.9M20.3M10.3M11.8M7.5M
Operating Income(17.7M)(57.9M)(20.3M)(10.3M)(9.3M)(9.7M)
Ebit(17.7M)(57.9M)(20.1M)(9.7M)(8.7M)(9.1M)
Research Development15.5M52.8M14.9M6.5M7.5M6.1M
Ebitda(17.5M)(57.7M)(20.0M)(9.6M)(8.6M)(9.0M)
Cost Of Revenue260K195K102K84K96.6K76.1K
Total Operating Expenses17.5M57.7M20.2M10.3M11.8M7.5M
Income Before Tax(17.7M)(57.9M)(20.1M)(9.7M)(8.7M)(9.1M)
Net Income(13.9M)(48.7M)(17.6M)(8.4M)(7.6M)(7.9M)
Income Tax Expense(3.8M)(9.2M)(2.4M)(1.2M)(1.1M)(1.2M)
Selling General Administrative2.2K5.0K5.4K3.8M4.3M4.5M
Net Income From Continuing Ops(13.9M)(48.7M)(17.6M)(8.4M)(7.6M)(7.9M)
Net Income Applicable To Common Shares(3.9M)(13.9M)(48.7M)(17.6M)(15.9M)(15.1M)
Tax Provision(3.8M)(9.2M)(2.4M)(1.2M)(1.1M)(1.2M)
Interest Income19K11K207K635K730.3K766.8K
Selling And Marketing Expenses2.0M4.8M5.3M73K84.0K79.8K
Reconciled Depreciation260K195K102K84K96.6K136.4K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
ZLABZai Lab
ASLEAerSale Corp
ATSAT S Austria

Other Information on Investing in Synairgen Stock

Synairgen plc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Synairgen Plc shareholders. The income statement also shows Synairgen investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Balance Sheet
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY